Web Results

Rofecoxib

en.wikipedia.org/wiki/Rofecoxib

Rofecoxib /ˌrɒfᵻˈkɒksɪb/ is a nonsteroidal anti-inflammatory drug (NSAID) that has now been withdrawn over safety concerns. It was marketed by Merck ...

Vioxx (rofecoxib) Questions and Answers - FDA

www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm106290.htm

What action did Merck take today? Merck announced a voluntary worldwide withdrawal of Vioxx (rofecoxib). 2. What is Vioxx? Vioxx is a COX-2 selective ...

Vioxx (Rofecoxib) Drug Information: Clinical Pharmacology ...

www.rxlist.com/vioxx-drug/clinical-pharmacology.htm

Learn about clinical pharmacology for the drug Vioxx (Rofecoxib).

Side Effects of Vioxx (Rofecoxib) Drug Center - RxList

www.rxlist.com/vioxx-side-effects-drug-center.htm

Oct 20, 2015 ... Find a comprehensive guide to possible side effects when taking Vioxx ( Rofecoxib) for Professionals, Patients, and Caregivers.

Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib ...

www.ncbi.nlm.nih.gov/pubmed/17605893

Curr Med Res Opin. 2007 Aug;23(8):1859-66. Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug ...

rofecoxib (Vioxx): Drug Facts, Side Effects and Dosing - MedicineNet

www.medicinenet.com/rofecoxib/article.htm

Sep 30, 2004 ... Get information on the arthritis drug rofecoxib (Vioxx) removed from the US market by the manufacturer.

Rofecoxib withdrawn - Medscape

www.medscape.com/viewarticle/782861

Sep 30, 2004 ... Whitehouse Station, NJ - Merck has withdrawn its selective COX-2 inhibitor rofecoxib (Vioxx<sup>®</sup>) from all markets worldwide, following the ...

DrugBank: Rofecoxib

www.drugbank.ca/drugs/DB00533

Rofecoxib is used for the treatment of osteoarthritis, rheumatoid arthritis, acute pain in adults, and primary dysmenorrhea, as well as acute treatment of migraine  ...

Cardiovascular Events Associated with Rofecoxib in a Colorectal ...

www.nejm.org/doi/full/10.1056/NEJMoa050493

Original Article from The New England Journal of Medicine — Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention ...

Failing the Public Health — Rofecoxib, Merck, and the FDA — NEJM

www.nejm.org/doi/full/10.1056/NEJMp048286

On May 21, 1999, Merck was granted approval by the Food and Drug Administration (FDA) to market rofecoxib (Vioxx). On September 30, 2004, after more than ...

Answer
rofecoxib | Define rofecoxib at Dictionary.com
dictionary.reference.com/browse/rofecoxib
The world's most popular free online dictionary with definitions, spell check, word origins, example sentences, audio pronunciations, Word of the Day and more!
More Info

Rofecoxib (oral) medical facts from Drugs.com

www.drugs.com

Rofecoxib (Vioxx) was withdrawn from the U.S. market in 2004. Rofecoxib is in a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Rofecoxib ...

Vioxx (Rofecoxib) Drug Information: Description, User Reviews ...

www.rxlist.com

Learn about the prescription medication Vioxx (Rofecoxib), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.

Lessons from the withdrawal of rofecoxib

www.ncbi.nlm.nih.gov

Oct 16, 2004 ... Lessons from the withdrawal of rofecoxib. Patients would be safer if drug companies disclosed adverse events before licensing. Paul A Dieppe ...